Structure Database (LMSD)


LMSD: Lipid classification search results

Sphingolipids [SP] (W) --> Neutral glycosphingolipids [SP05]
LM_IDCommon NameSystematic NameSpecies ShorthandFormulaMass
LMSP05000001SyriacinN-(34S-methyl-5Z,9Z,12Z,15Z,18Z,21Z-
hexatriacontahexaenoyl)-1-sulfo-β-D-
fucosyl-(16R-methyl-sphing-4-enine)
-C62H109NO10S1059.7772
LMSP05000002Galα1-6Glcβ-Cer(t17:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-
heptadecasphinganine)
-C51H99NO15965.7015
LMSP05000003Galα1-6Glcβ-Cer(t17:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-16-methyl-
hexadecasphinganine)
-C51H99NO15965.7015
LMSP05000004Galα1-6Glcβ-Cer(t18:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-sphinganine)
-C52H101NO15979.7171
LMSP05000005Galα1-6Glcβ-Cer(t18:0/21:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
heneicosanoyl)-4R-hydroxy-sphinganine)
-C51H99NO15965.7015
LMSP05000006Galα1-6Glcβ-Cer(t18:0/23:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
tricosanoyl)-4R-hydroxy-sphinganine)
-C53H103NO15993.7328
LMSP05000007Galα1-6Glcβ-Cer(t18:0/23:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
tricosanoyl)-4R-hydroxy-16-methyl-
heptasphinganine)
-C53H103NO15993.7328
LMSP05000008Galα1-6Glcβ-Cer(t18:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-16-methyl-
heptasphinganine)
-C52H101NO15979.7171
LMSP05000009Galα1-6Glcβ-Cer(t18:0/21:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
heneicosanoyl)-4R-hydroxy-16-methyl-
heptasphinganine)
-C51H99NO15965.7015
LMSP05000010Galα1-6Glcβ-Cer(t19:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-17-methyl-
sphinganine)
-C53H103NO15993.7328
LMSP05000011Galα1-6Glcβ-Cer(t19:1/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-17-methyl-
sphing-6E-enine)
-C52H99NO15977.7015
LMSP05000012Galα1-6Glcβ-Cer(t19:1/21:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
heneicosanoyl)-4R-hydroxy-17-methyl-
sphing-6E-enine)
-C51H97NO15963.6858
LMSP05000013Galα1-6Glcβ-Cer(t19:1/21:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
heneicosanoyl)-4R-hydroxy-16-methyl-
sphing-6E-enine)
-C51H97NO15963.6858
LMSP05000014Galα1-6Glcβ-Cer(t19:1/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-16-methyl-
sphing-6E-enine)
-C52H99NO15977.7015
LMSP05000015Galα1-6Glcβ-Cer(t19:0/22:0(2OH[R])1-O-melibiosoyl-(N-(2R-hydroxy-
docosanoyl)-4R-hydroxy-16-methyl-
sphinganine)
-C52H101NO15979.7171
LMSP05010031Glucosyl sphingosine1-β-glucosyl-sphing-4-enine-C24H47NO7461.3353
LMSP05010032FMC-5(d18:1/18:0)N-(octadecanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
-C52H91NO13937.6490
LMSP05010033FMC-5(d18:1/20:0)N-(eicosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
-C54H95NO13965.6803
LMSP05010034FMC-5(d18:1/22:0)N-(docosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
-C56H99NO13993.7116
LMSP05010035FMC-5(d18:1/24:0)N-(tetracosanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
-C58H103NO131021.7429
LMSP05010036FMC-5(d18:1/24:1)N-(15Z-tetracosenoyl)-1-β-(2',3',4',
6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
-C58H101NO131019.7273
LMSP05010037FMC-6(d18:1/24:0(2-OH))N-(2-hydroxy-tetracosanoyl)-1-β-(2',
3',4',6'-tetra-O-acetyl-galactosyl)-3-
O-acetyl-sphing-4-enine
-C58H103NO141037.7379
LMSP05010038FMC-6(d18:1/22:0(2-OH))N-(2-hydroxy-docosanoyl)-1-β-(2',3',
4',6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
-C56H99NO141009.7066
LMSP05010039Phalluside-1N-(2R-hydroxy-hexadecanoyl)-1-β-
glucosyl-9-methyl-sphing-4E,8E,10E-
trienine
HexCer 35:3;O3C41H75NO9725.5442
LMSP05010040Dracontioside AN-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 36:2;O3C42H79NO9741.5755
LMSP05010041Dracontioside BN-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
HexCer 42:1;O4C48H93NO10843.6799
LMSP05010042GlcCer(t18:1(8Z)/16:0(2OH[S]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
HexCer 34:1;O4C40H77NO10731.5547
LMSP05010043GlcCer(t18:1(8Z)/18:0(2OH[S]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
HexCer 36:1;O4C42H81NO10759.5860
LMSP05010044GlcCer(t18:1(8Z)/20:0(2OH[S]))N-(2R-hydroxyicosanoyl)-1-β-glucosyl-
4R-hydroxy-8Z-octadecasphingenine
HexCer 38:1;O4C44H85NO10787.6173
LMSP05010045GlcCer(t18:1(8Z)/22:0(2OH[S]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
4R-hydroxy-8Z-octadecasphingenine
HexCer 40:1;O4C46H89NO10815.6486
LMSP05010046GlcCer(d18:1(8Z)/25:0(2OH[R]))N-(2R-hydroxypentacosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
HexCer 43:1;O4C49H95NO10857.6956
LMSP05010047GlcCer(t18:1(8Z)/26:0(2OH[R]))N-(2R-hydroxyhexacosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
HexCer 44:1;O4C50H97NO10871.7112
LMSP05010048GlcCer(d18:2(4E,8Z)/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 34:2;O3C40H75NO9713.5442
LMSP05010049GlcCer(d18:2(4E,8Z)/17:0(2OH[R]))N-(2R-hydroxyheptadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 35:2;O3C41H77NO9727.5598
LMSP05010050GlcCer(d18:2(4E,8Z)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 36:2;O3C42H79NO9741.5755
LMSP05010051GlcCer(d18:2(4E,8Z)/19:0(2OH[R]))N-(2R-hydroxynonadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 37:2;O3C43H81NO9755.5911
LMSP05010052GlcCer(d18:2(4E,8Z)/20:0(2OH[R]))N-(2R-hydroxyeicosanoyl)-1-β-glucosyl-
4E,8Z-octadecasphingadienine
HexCer 38:2;O3C44H83NO9769.6068
LMSP05010053GlcCer(d18:2(4E,8Z)/21:0(2OH[R]))N-(2R-hydroxyheneicosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 39:2;O3C45H85NO9783.6224
LMSP05010055GlcCer(d18:2(4E,8Z)/22:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
4E,8Z-octadecasphingadienine
HexCer 40:2;O3C46H87NO9797.6381
LMSP05010056GlcCer(d18:2(4E,8Z)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 36:1;OC48H91NO9825.6694
LMSP05010057GlcCer(d18:2(4E,8Z)/25:0(2OH[R]))N-(2R-hydroxypentacosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
HexCer 43:2;O3C49H93NO9839.6850
LMSP05010058GlcCer(t18:1(8E)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4R-hydroxy-8E-
octadecasphingenine
HexCer 42:1;O4C48H93NO10843.6799
LMSP05010059GlcCer(d21:1(8E)(9Me)/15:0(2OH[R]))N-(2R-hydroxypentadecanoyl)-1-β-
glucosyl-9-methyl-8E-heneicosphingenine
HexCer 37:1;O3C43H83NO9757.6068
LMSP05010060GlcCer(d18:1(8E)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-8E-octadecasphingenine
HexCer 36:1;O3C42H81NO9743.5911
LMSP05010061GlcCer(d18:1(8E)/21:0(2OH[R]))N-(2R-hydroxyheneicosanoyl)-1-β-
glucosyl-8E-octadecasphingenine
HexCer 39:1;O3C45H87NO9785.6381
LMSP05010062GlcCer(d18:1(8E)/22:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
8E-octadecasphingenine
HexCer 40:1;O3C46H89NO9799.6537
LMSP05010063GlcCer(d18:1(8E)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-8E-octadecasphingenine
HexCer 42:1;O3C48H93NO9827.6850
LMSP05010064GlcCer(d18:2(4E,8E)/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4E,8E-octadecasphingadienine
HexCer 34:2;O3C40H75NO9713.5442
LMSP05010065GlcCer(d18:2(4E,8E)/20:0(2OH[R]))N-(2R-hydroxyicosanoyl)-1-β-glucosyl-
4E,8E-octadecasphingadienine
HexCer 38:2;O3C44H83NO9769.6068
LMSP05010066GlcCer(d18:2(4E,8E)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8E-octadecasphingadienine
HexCer 36:2;O3C42H79NO9741.5755

Showing page 1 of 47     Results:    1  2  3  4  5  Next  Last     Showing results 1 to 50 of 2302